Abstract
Reactive oxygen species (ROS) are extremely active molecules which are primarily consequential to aerobic metabolism. They serve as a “double-edged sword” by playing a regulatory role in both promotion and suppression of tumor. Cancer cells maintain a state of high ROS levels, whereas cancer stem cells (CSCs) survive in low ROS level which is crucial to maintain the self-renewal and stemness. Tumor hypoxia in CSCs is known for its significant role in EMT which may lead to cancer progression. Surprisingly, the generation of cells having stem cell properties is possible through EMT signaling. Interdependence of hypoxia, ROS production, EMT, and CSCs has been posited in the retrospective literature. CSCs are characterized by unique properties such as resistance to radio- and chemotherapy when compared to non-CSCs. The observation of CSCs holding enhanced protection mechanism from ROS-induced stress and a different metabolism from the differentiated part of the tumor has opened up a novel avenue in research, and it started developing drugs targeting CSC-specific signaling. Hence, the strategies that could increase the ROS and oxidative stress in CSCs might assist in eradication of these parent cells and a comprehensive picture about the CSC niche, and decoding the mechanisms of redox regulation in CSCs could lead to the discovery of therapeutic approaches for cancer. The chapter summarizes the role of ROS-induced tumor angiogenesis, metastasis and inflammation, ROS in the maintenance of CSCs, CSCs in EMT, and therapeutic targeting of CSCs.
References
Aggarwal V, Tuli HS, Varol A, Thakral F, Yerer MB, Sak K, Varol M, Jain A, Khan M, Sethi G (2019) Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomol Ther 9(11):735. https://doi.org/10.3390/biom9110735
Amamoto R, Arlotta P (2014) Development-inspired reprogramming of the mammalian central nervous system. Science 343(6170). https://doi.org/10.1126/science.1239882
Anido J, Sáez-Borderías A, Gonzàlez-Juncà A, Rodón L, Folch G, Carmona MA, Prieto-Sánchez RM, Barba I, Martínez-Sáez E, Prudkin L, Cuartas I (2010) TGF-β receptor inhibitors target the CD44high/Id1high glioma-initiating cell population in human glioblastoma. Cancer Cell 18(6):655–668. https://doi.org/10.1016/j.ccr.2010.10.023
Aprikian AG, Tremblay L, Han K, Chevalier S (1997) Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins. Int J Cancer 72(3):498–504. https://doi.org/10.1002/(SICI)1097-0215(19970729)72:3<498::AID-IJC19>3.0.CO;2-8
Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K, Ito K, Koh GY, Suda T (2004) Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118(2):149–161. https://doi.org/10.1016/j.cell.2004.07.004
Aydin E, Johansson J, Nazir FH, Hellstrand K, Martner A (2017) Role of NOX2-derived reactive oxygen species in NK cell–mediated control of murine melanoma metastasis. Cancer Immunol Res 5(9):804–811. https://doi.org/10.1158/2326-6066.CIR-16-0382
Ayob AZ, Ramasamy TS (2018) Cancer stem cells as key drivers of tumour progression. J Biomed Sci 25(1):1–18. https://doi.org/10.1186/s12929-018-0426-4
Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539–545
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120):756–760. https://doi.org/10.1038/nature05236
Bhandari DR, Seo KW, Roh KH, Jung JW, Kang SK, Kang KS (2010) REX-1 expression and p38 MAPK activation status can determine proliferation/differentiation fates in human mesenchymal stem cells. PLoS One 5(5):e10493. https://doi.org/10.1371/journal.pone.0010493
Binker MG, Binker-Cosen AA, Richards D, Oliver B, Cosen-Binker LI (2009) EGF promotes invasion by PANC-1 cells through Rac1/ROS-dependent secretion and activation of MMP-2. Biochem Biophys Res Commun 379(2):445–450. https://doi.org/10.1016/j.bbrc.2008.12.080
Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3(7):730–737. https://doi.org/10.1038/nm0798-822
Bussolati B, Grange C, Sapino A, Camussi G (2009) Endothelial cell differentiation of human breast tumour stem/progenitor cells. J Cell Mol Med 13(2):309–319. https://doi.org/10.1111/jcmm.16169
Carnero A, Lleonart M (2016) The hypoxic microenvironment: a determinant of cancer stem cell evolution. Inside the Cell 1(2):96–105. https://doi.org/10.1002/icl3.1039
Chatterjee R, Chatterjee J (2020) ROS and oncogenesis with special reference to EMT and stemness. Eur J Cell Biol 99(2–3):151073. https://doi.org/10.1016/j.ejcb.2020.151073
Che N, Yang Z, Liu X, Li M, Feng Y, Zhang C, Li C, Cui Y, Xuan Y (2021) Suppression of LETM1 inhibits the proliferation and stemness of colorectal cancer cells through reactive oxygen species–induced autophagy. J Cell Mol Med 25(4):2110–2120. https://doi.org/10.1111/jcmm.16169
Cheng L, Huang Z, Zhou W, Wu Q, Donnola S, Liu JK, Fang X, Sloan AE, Mao Y, Lathia JD, Min W (2013) Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell 153(1):139–152. https://doi.org/10.1016/j.cell.2013.02.021
Clement V, Dutoit V, Marino D, Dietrich PY, Radovanovic I (2009) Limits of CD133 as a marker of glioma selfrenewing cells. Int J Cancer 125(1):244–248. https://doi.org/10.1002/ijc.24352
D’Autréaux B, Toledano MB (2007) ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8(10):813–824. https://doi.org/10.1038/nrm2256
Dando I, Cordani M, DallaPozza E, Biondani G, Donadelli M, Palmieri M (2015) Antioxidant mechanisms and ROS-related microRNAs in cancer stem cells. Oxidative Med Cell Longev 2015. https://doi.org/10.1155/2015/425708
De Francesco EM, Maggiolini M, Tanowitz HB, Sotgia F, Lisanti MP (2017) Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: implications for optimizing anti-angiogenic therapy. Oncotarget 8(34):56126. https://doi.org/10.18632/oncotarget.18445
Dey-Guha I, Wolfer A, Yeh AC, Albeck JG, Darp R, Leon E, Wulfkuhle J, Petricoin EF, Wittner BS, Ramaswamy S (2011) Asymmetric cancer cell division regulated by AKT. Proc Natl Acad Sci 108(31):12845–12850. https://doi.org/10.1073/pnas.1109632108
Dickinson BC, Chang CJ (2011) Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat Chem Biol 7(8):504–511. https://doi.org/10.1038/nchembio.607
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B (2009) Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458(7239):780–783. https://doi.org/10.1038/nature07733
Dong C, Yuan T, Wu Y, Wang Y, Fan TW, Miriyala S, Lin Y, Yao J, Shi J, Kang T, Lorkiewicz P (2013) Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell 23(3):316–331. https://doi.org/10.1016/j.ccr.2013.01.022
Dou C, Fang C, Zhao Y, Fu X, Zhang Y, Zhu D, Wu H, Liu H, Zhang J, Xu W, Liu Z (2017) BC-02 eradicates liver cancer stem cells by upregulating the ROS-dependent DNA damage. Int J Oncol 51(6):1775–1784. https://doi.org/10.3892/ijo.2017.4159
Farina AR, Di Ianni N, Cappabianca L, Ruggeri P, Ragone M, Ianni G, Gulino A, Mackay AR (2013) TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype. Biomed Res Int 2013. https://doi.org/10.1155/2013/740187
Ferraro D, Corso S, Fasano E, Panieri E, Santangelo R, Borrello S, Giordano S, Pani G, Galeotti T (2006) Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS). Oncogene 25(26):3689–3698. https://doi.org/10.1038/sj.onc.1209409
Finkel T (1998) Oxygen radicals and signaling. Curr Opin Cell Biol 10(2):248–253. https://doi.org/10.1016/s0955-0674(98)80147-6
Finkel T (2011) Signal transduction by reactive oxygen species. J Cell Biol 194(1):7–15. https://doi.org/10.1083/jcb.201102095
Fukai T, Ushio-Fukai M (2020) Cross-talk between NADPH oxidase and mitochondria: role in ROS signaling and angiogenesis. Cell 9(8):1849. https://doi.org/10.3390/cells9081849
Gammon L, Biddle A, Heywood HK, Johannessen AC, Mackenzie IC (2013) Sub-sets of cancer stem cells differ intrinsically in their patterns of oxygen metabolism. PLoS One 8(4):e62493. https://doi.org/10.1371/journal.pone.0062493
Han J, Sun P (2007) The pathways to tumor suppression via route p38. Trends Biochem Sci 32(8):364–371. https://doi.org/10.1016/j.tibs.2007.06.007
Haraguchi N, Ishii H, Mimori K, Tanaka F, Ohkuma M, Kim HM, Akita H, Takiuchi D, Hatano H, Nagano H, Barnard GF (2010) CD13 is a therapeutic target in human liver cancer stem cells. J Clin Invest 120(9):3326–3339. https://doi.org/10.1172/JCI42550
Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H, Masuko T (2011) CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc− and thereby promotes tumor growth. Cancer Cell 19(3):387–400. https://doi.org/10.1016/j.ccr.2011.01.038
Ito K, Bernardi R, Morotti A, Matsuoka S, Saglio G, Ikeda Y, Rosenblatt J, Avigan DE, Teruya-Feldstein J, Pandolfi PP (2008) PML targeting eradicates quiescent leukaemia-initiating cells. Nature 453(7198):1072–1078. https://doi.org/10.1038/nature07016
Jang YY, Sharkis SJ (2007) A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 110(8):3056–3063. https://doi.org/10.1182/blood-2007-05-087759
Jin Y, Lu Z, Ding K, Li J, Du X, Chen C, Sun X, Wu Y, Zhou J, Pan J (2010) Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-κB pathway and generation of reactive oxygen species. Cancer Res 70(6):2516–2527. https://doi.org/10.1158/0008-5472.CAN-09-3950
Jin M, Wang J, Ji X, Cao H, Zhu J, Chen Y, Yang J, Zhao Z, Ren T, Xing J (2019) MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma. J Exp Clin Cancer Res 38(1):1–13. https://doi.org/10.1186/s13046-019-1135-x
Jing Y, Liu LZ, Jiang Y, Zhu Y, Guo NL, Barnett J, Rojanasakul Y, Agani F, Jiang BH (2012) Cadmium increases HIF-1 and VEGF expression through ROS, ERK, and AKT signaling pathways and induces malignant transformation of human bronchial epithelial cells. Toxicol Sci 125(1):10–19. https://doi.org/10.1093/toxsci/kfr256
Karar J, Maity A (2011) PI3K/AKT/mTOR pathway in angiogenesis. Front Mol Neurosci 4:51. https://doi.org/10.3389/fnmol.2011.00051
Kashyap D, Sharma A, Sak K, Tuli HS, Buttar HS, Bishayee A (2018) Fisetin: a bioactive phytochemical with potential for cancer prevention and pharmacotherapy. Life Sci 194:75–87. https://doi.org/10.1016/j.lfs.2017.12.005
Kashyap D, Tuli HS, Sak K, Garg VK, Goel N, Punia S, Chaudhary A (2019) Role of reactive oxygen species in cancer progression. Curr Pharmacol Rep 5(2):79–86. https://doi.org/10.3390/biom9110735
Kidd ME, Shumaker DK, Ridge KM (2014) The role of vimentin intermediate filaments in the progression of lung cancer. Am J Respir Cell Mol Biol 50(1):1–6. https://doi.org/10.1165/rcmb.2013-0314TR
Kim HM, Haraguchi N, Ishii H, Ohkuma M, Okano M, Mimori K, Eguchi H, Yamamoto H, Nagano H, Sekimoto M, Doki Y (2012) Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial–mesenchymal transition-like phenomenon. Ann Surg Oncol 19(3):539–548. https://doi.org/10.1245/s10434-011-2040-5
Komatsu D, Kato M, Nakayama J, Miyagawa S, Kamata T (2008) NADPH oxidase 1 plays a critical mediating role in oncogenic Ras-induced vascular endothelial growth factor expression. Oncogene 27(34):4724–4732. https://doi.org/10.1038/0nc.2008.102
Krishnamachary B, Zagzag D, Nagasawa H, Rainey K, Okuyama H, Baek JH, Semenza GL (2006) Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor–null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 66(5):2725–2731. https://doi.org/10.1158/0008-5472.CAN-05-3719
Lafarga V, Cuadrado A, Nebreda AR (2007) p18Hamlet mediates different p53-dependent responses to DNA damage inducing agents. Cell Cycle 6(19):2319–2322. https://doi.org/10.4161/cc.6.19.4741
Lee KH, Kim SW, Kim JR (2009) Reactive oxygen species regulate urokinase plasminogen activator expression and cell invasion via mitogen-activated protein kinase pathways after treatment with hepatocyte growth factor in stomach cancer cells. J Exp Clin Cancer Res 28(1):1–9. https://doi.org/10.1186/1756-9966-28-73
Li Z, Rich JN (2010) Hypoxia and hypoxia inducible factors in cancer stem cell maintenance. In: Simon M (ed) Diverse effects of hypoxia on tumor progression. Current topics in microbiology and immunology, vol 345. Springer, Berlin, Heidelberg. https://doi.org/10.1007/82_2010_75
Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G (2008) Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 135(6):2128–2140. https://doi.org/10.1053/j.gastro.2008.07.027
Lin CJ, Lee CC, Shih YL, Lin CH, Wang SH, Chen TH, Shih CM (2012) Inhibition of mitochondria-and endoplasmic reticulum stress-mediated autophagy augments temozolomide-induced apoptosis in glioma cells. PLoS One 7(6):e38706. https://doi.org/10.1371/journal.pone.0038706
Liou GY, Storz P (2010) Reactive oxygen species in cancer. Free Radic Res 44(5):479–496. https://doi.org/10.3109/10715761003667554
Luo M, Shang L, Brooks MD, Jiagge E, Zhu Y, Buschhaus JM, Conley S, Fath MA, Davis A, Gheordunescu E, Wang Y (2018) Targeting breast cancer stem cell state equilibrium through modulation of redox signaling. Cell Metab 28(1):69–86. https://doi.org/10.1016/j.cmet.2018.06.006
Mahller YY, Williams JP, Baird WH, Mitton B, Grossheim J, Saeki Y, Cancelas JA, Ratner N, Cripe TP (2009) Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus. PLoS One 4(1):e4235. https://doi.org/10.1371/journal.pone.0004235
McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, Stivala F (2007) Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochimica et Biophysica Acta (BBA) Mol Cell Res 1773(8):1263–1284. https://doi.org/10.1016/j.bbamcr.2006.10.001
Morrison SJ, Spradling AC (2008) Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 132(4):598–611. https://doi.org/10.1016/j.cell.2008.01.038
Nagano O, Okazaki S, Saya H (2013) Redox regulation in stem-like cancer cells by CD44 variant isoforms. Oncogene 32(44):5191–5198. https://doi.org/10.1038/onc.2012.638
Pan JS, Hong MZ, Ren JL (2009) Reactive oxygen species: a double-edged sword in oncogenesis. World J Gastroenterol: WJG 15(14):1702. https://doi.org/10.3748/wjg.15.1702
Pastò A, Bellio C, Pilotto G, Ciminale V, Silic-Benussi M, Guzzo G, Rasola A, Frasson C, Nardo G, Zulato E, Nicoletto MO (2014) Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation. Oncotarget 5(12):4305. https://doi.org/10.18632/oncotarget.2010
Pelicano H, Lu W, Zhou Y, Zhang W, Chen Z, Hu Y, Huang P (2009) Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism. Cancer Res 69(6):2375–2383. https://doi.org/10.1158/0008-5472.CAN-08-3359
Rabbani ZN, Spasojevic I, Zhang X, Moeller BJ, Haberle S, Vasquez-Vivar J, Dewhirst MW, Vujaskovic Z, Batinic-Haberle I (2009) Antiangiogenic action of redox-modulating Mn (III) meso-tetrakis (N-ethylpyridinium-2-yl) porphyrin, MnTE-2-PyP5+, via suppression of oxidative stress in a mouse model of breast tumor. Free Radic Biol Med 47(7):992–1004. https://doi.org/10.1016/j.freeradbiomed.2009.07.001
Rakoff-Nahoum S (2006) Cancer issue: why cancer and inflammation? Yale J Biol Med 79(3–4):123
Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49(11):1603–1616
Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, Hintz L, Nusse R, Weissman IL (2003) A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423(6938):409–414. https://doi.org/10.1038/nature01593
Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G, Larocca LM, De Maria R (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468(7325):824–828. https://doi.org/10.1038/nature09557
Rigiracciolo DC, Scarpelli A, Lappano R, Pisano A, Santolla MF, De Marco P, Cirillo F, Cappello AR, Dolce V, Belfiore A, Maggiolini M (2015) Copper activates HIF-1α/GPER/VEGF signalling in cancer cells. Oncotarget 6(33):34158. https://doi.org/10.18632/oncotarget.5779
Ruggeri P, Farina AR, Di Ianni N, Cappabianca L, Ragone M, Ianni G, Gulino A, Mackay AR (2014) The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype. PLoS One 9(4):e94568. https://doi.org/10.1371/journal.pone.0094568
Scheel C, Eaton EN, Li SHJ, Chaffer CL, Reinhardt F, Kah KJ, Bell G, Guo W, Rubin J, Richardson AL, Weinberg RA (2011) Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145(6):926–940. https://doi.org/10.1016/j.cell.2011.04.029
Schieber MS, Chandel NS (2013) ROS links glucose metabolism to breast cancer stem cell and EMT phenotype. Cancer Cell 23(3):265–267. https://doi.org/10.1016/j.ccr.2013.02.021
Schieber M, Chandel NS (2014) ROS function in redox signaling and oxidative stress. Curr Biol 24(10):R453–R462. https://doi.org/10.1016/j.cub.2014.03.034
Semenza GL (2014) Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Ann Rev Pathol Mechanisms Disease 9:47–71. https://doi.org/10.1146/annurev-pathol-012513-104720
Seo EJ, Kim DK, Jang IH, Choi EJ, Shin SH, Lee SI, Kwon SM, Kim KH, Suh DS, Kim JH (2016) Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancer. Oncotarget 7(34):55624. https://doi.org/10.18632/oncotarget.10954
Shi X, Zhang Y, Zheng J, Pan J (2012) Reactive oxygen species in cancer stem cells. Antioxid Redox Signal 16(11):1215–1228. https://doi.org/10.1089/ars.2012.4529
Shimao Y, Nabeshima K, Inoue T, Koono M (1999) TPA-enhanced motility and invasion in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1: selective role of PKC-α and its inhibition by a combination of PDBu-induced PKC downregulation and antisense oligonucleotides treatment. Clin Exp Metastasis 17(4):349–358. https://doi.org/10.1023/A:1006696331420
Shinohara M, Adachi Y, Mitsushita J, Kuwabara M, Nagasawa A, Harada S, Furuta S, Zhang Y, Seheli K, Miyazaki H, Kamata T (2010) Reactive oxygen generated by NADPH oxidase 1 (Nox1) contributes to cell invasion by regulating matrix metalloprotease-9 production and cell migration. J Biol Chem 285(7):4481–4488. https://doi.org/10.1074/jbc.M109.071779
Soda Y, Marumoto T, Friedmann-Morvinski D, Soda M, Liu F, Michiue H, Pastorino S, Yang M, Hoffman RM, Kesari S, Verma IM (2011) Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci 108(11):4274–4280. https://doi.org/10.1073/pnas.1016030108
Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, Cullen DE, McDowell EP, Lazo-Kallanian S, Williams IR, Sears C, Armstrong SA (2007) FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128(2):325–339. https://doi.org/10.1016/j.cell.2007.01.003
Ushio-Fukai M, Alexander RW (2004) Reactive oxygen species as mediators of angiogenesis signaling. Role of NAD (P) H oxidase. Mol Cell Biochem 264(1):85–97. https://doi.org/10.1023/B:MCBI.0000044378.09409.b5
Ushio-Fukai M, Nakamura Y (2008) Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer let 266(1):37–52. https://doi.org/10.1016/j.canlet.2008.02.044
Wang P, Zeng Y, Liu T, Zhang C, Yu PW, Hao YX, Luo HX, Liu G (2014) Chloride intracellular channel 1 regulates colon cancer cell migration and invasion through ROS/ERK pathway. World J Gastroenterol: WJG 20(8):2071. https://doi.org/10.3748/wjg.v20.i8.2071
Wang C, Shao L, Pan C, Ye J, Ding Z, Wu J, Du Q, Ren Y, Zhu C (2019) Elevated level of mitochondrial reactive oxygen species via fatty acid β-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial–mesenchymal transition. Stem Cell Res Ther 10(1):1–16. https://doi.org/10.1186/s13287-019-1265-2
Waris G, Ahsan H (2006) Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinogenesis 5:14. https://doi.org/10.1186/1477-3163-5-14
Westermarck J, Li SP, Kallunki T, Han J, Kähäri VM (2001) p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression. Mol Cell Biol 21(7):2373–2383. https://doi.org/10.1128/mcb.21.7.2373-2383.2001
Woo JH, Lim JH, Kim YH, Suh SI, Chang JS, Lee YH, Park JW, Kwon TK (2004) Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC δ signal transduction. Oncogene 23(10):1845–1853. https://doi.org/10.1038/sj.onc.1207307
Wu WS (2006) The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev 25(4):695–705. https://doi.org/10.1007/s10555-006-9037-8
Wurmser AE, Nakashima K, Summers RG, Toni N, D’amour KA, Lie DC, Gage FH (2004) Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature 430(6997):350–356. https://doi.org/10.1038/nature02604
Yeung TM, Gandhi SC, Bodmer WF (2011) Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells. Proc Natl Acad Sci 108(11):4382–4387. https://doi.org/10.1073/pnas.1014519107
Zhang Y, Qi X, Gong L, Li Y, Liu L, Xue X, Xiao Y, Wu X, Ren J (2008) Roles of reactive oxygen species and MAP kinases in the primary rat hepatocytes death induced by toosendanin. Toxicology 249(1):62–68. https://doi.org/10.1016/j.tox.2008.04.005
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2022 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Vishnupriya, P., Aparna, A., Vijaya Padma, V. (2022). Functional Correlation Between ROS and Cancer Stem Cells in Cancer Progression. In: Chakraborti, S. (eds) Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Springer, Singapore. https://doi.org/10.1007/978-981-16-5422-0_89
Download citation
DOI: https://doi.org/10.1007/978-981-16-5422-0_89
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-5421-3
Online ISBN: 978-981-16-5422-0
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences